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1. Introduction 
Human plasma chylomicrons and very low density 
lipoproteins contain 3 low Mr proteins called apolipo- 
protein C-I, C-II and C-III (review [l-3]). Apolipo- 
protein C-II plays an important role in the catabolism 
of triglyceride-rich lipoproteins by increasing the 
activity of lipoprotein lipase [4]; the metabolic roles 
of apoC-I and apoC-III are not firmly established. The 
Capolipoproteins are thought o interact with phos- 
pholipids at the monolayer surface of the lipoproteins 
[3]. During catabolism of triglyceride-rich lipoprotein, 
the C-apolipoproteins, along with phospholipid and 
unesterified cholesterol, transfer to high density lipo- 
proteins (HDL). It is not known whether the C-apo- 
lipoproteins alter the phospholipid structure of the 
lipoprotein so as to influence their metabolism. Here, 
we investigate the effect of the C-apolipoproteins on 
the molecular organization of phospholipids. Using 
fluorescently labeled sonicated vesicles of dipalmitoyl- 
phosphatidylcholine, we have determined the effects 
of the C-apolipoproteins on phospholipid structure. 
from Sigma. Apolipoproteins C-I, C-II and C-III were 
purified from human plasma VLDL following lipid 
extraction, gel exclusion chromatography on Sephadex 
G-75 and DEAE ion-exchange chromatography in the 
presence of 8 M urea as in [5]. The phospholipid- 
binding fragment of apolipoprotein C-I (residues 
l-38) and the non-lipid-binding fragment (39-57) 
were obtained by cyanogen bromide cleavage of the 
intact protein [6]. Concentrations and criteria for 
purity of apolipoproteins and peptide fragments were 
established by amino acid compositional nalyses. 
Unilamellar vesicles of dipalmitoylphosphatidyl- 
choline were prepared by sonication (model W-225R, 
Heat Systems Ultrasonics, Inc.). Dipalmitoylphospha- 
tidylcholine was sonicated above its phase-transition 
temperature at 10 mg lipid/ml standard buffer 
(10 mM Tris-HCl, 0.9% NaCl, 0.01% NaN3, pH 7.4). 
Multilamellar structures were removed by centrifuga- 
tion at 100 000 X g for 1 h at 15°C. Phospholipid 
was determined as in [7]. 
2. Materials and methods 
Dipalmitoylphosphatidylcholine (Sigma) gave a 
single species on a thin-layer plate of silica gel (CHCIJ/ 
CH30H/H20, 65:25:4, by vol.). The fluorescent 
probes 2- and 12-(9-anthroyloxy)-stearic cid were 
obtained from Molecular Probes, Inc. The lipophilic 
probe 1,6-diphenyl-1,3,5-hexatriene was purchased 
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Lipid vesicles (200 fig/ml) were fluorescently 
labeled using a 1:200 probe:phospholipid molar ratio. 
The incorporation of 2- and 12(9-anthroyloxy)-steak 
acid into sonicated vesicles of dipalmitoylphospha- 
tidylcholine was achieved by bath sonication (model 
8846-50, Cole-Parmer) at 42’C for 20 min. The incor- 
poration of the fluorescent probe 1,6-diphenyl-1,3,5- 
hexatriene into the vesicles was monitored by the 
increase in fluorescence intensity as a function of time 
at 42°C [8]. Apolipoprotein-lipid complexes were 
prepared by adding vesicles of dipalmitoylphospha- 
tidylcholine to a 1.2 I.IM solution of apolipoprotein i  
standard buffer at 42°C. The interaction of apolipo- 
protein and lipid was monitored by the increase in tryp- 
tophan fluorescence [3] whereas circular dichroism 
(CD) was used for the apolipoprotein C-I lipid-binding 
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fragment [6]; phospholipid was added until there was 
no further change in fluorescence or CD. At this point, 
the [dipalmitoylphosphatidylcholine]/[peptide] 
ratios for apolipoproteins C-I, C-II and C-III and the 
apolipoprotein C-I lipid-binding fragment were 130, 
250,250 and 180, respectively. 
Fluorescence measurements were conducted on a 
Perkin-Elmer MPF 44-A ratio recording thermoregu- 
lated spectrofluorimeter. Fluorescence polarization 
(P) was determined by the relation P = (V, - L,)/ 
(Vv t I,,), where I’, and L, are the fluorescence 
intensities measured with polarizers parallel and per- 
pendicular to the vertically polarized exciting beam, 
respectively. Fluorescence polarization values were 
corrected for the unequal transmission of polarization 
intensities due to dispersion at the emission mono- 
chrometer grating. Polarization studies were con- 
ducted with the Perkin-Elmer Polarization Accessory 
063-0468. Excitation, emission wavelength pairs for 
2(9-anthroyloxy)-steak acid, 12-(9-anthroyloxy) 
stearic acid and 1,6-diphenyl-1,3,5-hexatriene wer  
365,435 nm; 365,435 nm; and 358,425 nm, respec- 
tively. The thermotropic properties of probe-labeled 
vesicles in the presence and absence of apolipoproteins 
were quantified by measuring the fluorescence polar- 
ization at 0.5-I .O”C gradations. Solid lines through 
the experimental points were constructed by linear 
regressional nalyses. For clarity, the experimental 
points of fig.1 and 2 are shown every 1-2’C. 
3. Results 
Sonicated vesicles of dipalmitoylphosphatidylcho- 
line were labeled with either 2- or 12-(9-anthroyloxy)- 
steak acids or 1,6-diphenyl-1,3,5-hexatriene, a d the 
temperature dependence of the fluorescence polariza- 
tion of these probe-labeled lipid vesicles was measured 
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Fig.1. The fluorescence polarization of 2-and 12-(9-anthroyloxy)-stearic a ids (2-AS and 12-A& respectively) and 1,6diphenyl- 
1,3,5-hexatriene (DPH) incorporated into sonicated vesicles of dipalmitoylphosphatidylcholine (DPPC) in the absence (0) and 
presence (0) of either apolipoprotein C-I, C-II or C-III. Apolipoprotein-lipid complexes were prepared as described in the text. 
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in the presence and absence of apolipoprotein. The 
effect of the C-apolipoproteins on these probe labeled 
vesicles was the following: to increase the fluorescence 
polarization over the investigated temperature range; 
to increase the phase-transition temperature by -2°C; 
to shift the onset of gel-state formation to higher 
temperatures; and to increase the rate of gellation. 
These apoprotein-induced changes in fluorescence 
polarization are consistent with an increase in the 
rigidity of the phospholipid bilayer structure. 
Fig.2 illustrates the temperature dependence of
the fluorescence polarization of vesicles in the presence 
and absence of residues l-38 of apolipoprotein C-I. 
In these experiments, 1,6-diphenyl-I ,3,5-hexatriene 
was used since this probe exhibits the largest polariza- 
tion change (fig.1). Residues I-38 of apolipoprotein 
C-I exhibit the same general effects as the intact apo- 
lipoproteins upon the thermotropic properties of the 
lipid. In contrast, when the non-lipid binding frag- 
ment of apolipoprotein C-I (residues 39-57) was 
co-incubated with vesicles, no increase in polarization 
of the probe was observed over those values obtained 
for dipalmitoylphosphatidylcholine vesicles alone. 
Table 1 summarizes the data of fig.l,2. These data 
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Fig.2. The fluorescence polarization of 1,6_diphenyl-1,3,5- 
hexatriene incorporated into sonicated vesicles of dipalmi- 
toylphosphatidylcholine (0) and in the presence of either res- 
idues l-38 of apolipoprotein C-I (0) or residues 39-57 (A). 
in the presence and absence of apolipoproteins C-I, 
C-II and C-III. Fig.1 shows that upon cooling, 2- and 
12-(9anthroyloxy)-steak acids and 1,6diphenyl- 
1,3,5_hexatriene report a sharp lipid phase-transition 
Table 1 
Summary of physical parameters 
Apoprotein Probe APT (48°C) APgb (30°C) AT, (“C)c 
C-I 
C-II 
C-III 
2-(9-anthroyloxy)-Stearic acid 1.13 18 22 
2-(9anthroyIoxy)Stearic acid 1.42 18 42 
2-(9-anthroyloxy)-Stearic acid 1.15 22 26 
12-(9-anthroyloxy)-Steak acid 1.33 2 21 
12-(9-anthroyloxy)-Stearic a id 1.60 2 38 
12-(9anthroyloxy)Stearic acid 1.30 2 17 
1.5 
2.0 
1.9 
C-I 
C-II 
C-III 
1.5 
2.0 
2.0 
C-I 
C-II 
C-III 
C-I 
(residues l-38) 
1,6-Diphenyl-1,3,5_hexatriene 1.22 15 30 2.6 
1,6-Diphenyl-1,3,5-hexatriene 1.51 15 55 2.2 
1,6-Diphenyl-1,3,5-hexatriene 1.25 15 30 2.4 
1,6-Diphenyl-1,3,5llexatriene 1.23 13 27 1.5 
a The term AA/ATis a measure of the dynamic change in polarization amplitude in the region of the phase-transition; AA is the 
change in phase-transition amplitude as illustrated in fig.1 and ATrepresents the temperature interval in which AA occurs. 
AA /“Tp and ti/ATrepresent the rate of gelling of dipalmitoylphosphatidylcholine in the presence and absence of apolipo- 
pro P. em, respectively. A ratio of these parameters >l.O is a measure of the apoprotein-induced increase in gellation rate 
b The values of APl (48°C) and APg (30°C) represent he difference in polarization values (aP) of probe-labeled vesicles of dipal- 
mitoylphosphatidylcholine in the presence and absence of apoprotein at 48°C and 3O”C, respectively. The subscripts ‘1’ and ‘g’ 
refer to the assumed physical state of the lipid as either liquidcrystalline (48°C) or gel-crystalline (30”(Z), respectively, in the 
regions outside the transition interval as shown in fig.1 
’ These data represent he magnitude of the apoproteininduced shift in the phase-transition temperature of the probe-labeled ves- 
icles 
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illustrate the change in fluorescence polarization as a 
function of apolipoprotein, probe location in the 
bilayer and physical state of the lipid. In the phase- 
transition region, the incremental change in polariza- 
tion amplitude per unit change in temperature 
(&t/AT) was greater in the presence than in the 
absence of apolipoproteins, i.e., the ratios AA,/AT,: 
u/AT > 1 .O. Thus, apolipoproteins appear to 
increase the rate of gellation of dipalmitoylphospha- 
tidylcholine. The most pronounced effect of the apo- 
lipoproteins on lipid structure, as reported by each 
probe, was to increase the rigidity of the phospholipid. 
Moreover, 12-(9-anthroyloxy)-stearic acid reported 
greater ates of gellation than 2-(9-anthroyloxy)-stearic 
acid in the presence of apolipoproteins. Also, the 
magnitude of the transition amplitudes (aAP) was 
smaller for 2-(9-anthroyloxy)-stearic acid than for 
12-(9anthroyloxy)-stearic acid. These effects in rate 
and magnitude are likely due to the smaller changes 
in microviscosity which occur near the glycerol head 
region of phosphatidylcholine relative to the center 
of the bilayer as the temperature is increased through 
the phase-transition region. Similar f5nlings were 
reported in [9]. The apolipoproteins produced a change 
in polarization amplitude (AP) in the liquid crystal- 
line (1) and gel-crystalline (g) states of the lipid. The 
AP, for 2-(9anthroyloxy)stearic acid, measured at 
48’C, is greater than the AP1 for 12-(9-anthroyloxy) 
stearic acid; APp values, measured at 3O”C, were 
approximately the same. These results suggest hat 
apolipoproteins increase bilayer rigidity at the 2-posi- 
tion over the complete temperature range. At the 
lZposition, however, apolipoproteins increase bilayer 
rigidity more dramatically in the gel-state than in the 
liquid-crystalline state of the lipid. In addition, apo- 
lipoprotein C-II caused a larger increase in gellation 
rate in the phase-transition region (A$/AT,) and a 
larger change in APa than apolipoprotein C-III, C-I or 
residues l-38 of apolipoprotein C-I. 
4. Discussion 
These findings, showing that the C-apolipoproteins 
increase the rigidity of phospholipids, are consistent 
with other studies with different apoproteins andlipid 
systems [lo-131. In [lo], 2-(9-anthroyloxy)-palmitic 
acid and 12-(9anthroyloxy)-stearic acid were used to 
monitor the fluorescence polarization changes in soni- 
cated dimyristoylphosphatidylcholine vesicles in the 
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presence and absence of the apolipoproteins of por- 
cine HDL. Their experiments showed a greater apo- 
protein-induced increase in fluorescence polarization 
in the liquid-crystalline state (3O’C) at the 2-position 
as compared to the 12-position of the phospholipid 
acyl chain. Human apolipoproteins were also shown to 
increase the fluorescence polarization of 1,6diphenyl- 
1,3,5-hexatriene in vesicles of dimyristoylphospha- 
tidylcholine throughout the phase-transition region 
[11,12]. 
C-Apolipoproteins increase the rigidity of dipalmi- 
toylphosphatidylcholine at both the 2- and 12-posi- 
tions of the bilayer. Residues l-38 of apolipoprotein 
C-I, but not residues 399.57, have effects similar in 
magnitude on lipid fluidity to those induced by intact 
apolipoprotein C-I. In the liquid-crystalline state, 
however, the apolipoproteininduced acyl chain crys- 
tallization of lipid molecules occurs more dramatically 
at the 2-position than the 12-position of the bilayer. 
These apolipoproteininduced increases in bilayer 
rigidity are likely to be mediated through the lipid- 
binding portion of the apolipoproteins. It is apparent 
from the data in fig.1 and table 1 that apolipoprotein 
C-II causes the largest perturbations in lipid structure. 
Whether these apolipoprotein C-II effects are related 
to the role of apolipoprotein C-II in increasing the 
activity of lipoprotein lipase is unknown but under 
investigation. 
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